Rodrigo Dienstmann
Universitat de Vic - Universitat Central de Catalunya(ES)Hebron University(PS)Vall d'Hebron Institut de Recerca(ES)Vall d'Hebron Hospital Universitari(ES)CIBBIM-Nanomedicine(ES)Sociedade Brasileira de Oncologia Clínica(BR)Vall d'Hebron Institute of Oncology(ES)Vall d'Hebron Institute of Oncology
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Genetic factors in colorectal cancer, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → The consensus molecular subtypes of colorectal cancer(2015)5,121 cited
- → Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group(2020)1,151 cited
- → Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer(2017)1,000 cited
- → Development of PI3K inhibitors: lessons learned from early clinical trials(2013)761 cited
- → A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)(2018)749 cited
- → CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer(2017)658 cited